COLORECTAL CANCER

Oct 29 2025HEALTH

Walking and Grip Strength: Simple Tests for Better Lives After Colorectal Cancer

In Europe, the number of people living with cancer is growing by 3. 5% each year since 2010. Out of all these survivors, 38% will live a decade or more after their diagnosis. Colorectal cancer (CRC) is the second most common cancer among survivors, and many of them will be over 75 years old, needing

reading time less than a minute
Oct 26 2025HEALTH

A New Hope in the Fight Against Colon Cancer

Colon cancer is a serious disease that takes many lives. Scientists have found that a protein called B7-H4 is more active in colon cancer cells than in healthy cells. This protein helps cancer cells grow. So far, no medicines have been made to target B7-H4 in colon cancer treatment. Researchers set

reading time less than a minute
Oct 18 2025HEALTH

How Food, Environment, and Genes Team Up in Colon Cancer

Colon cancer is a big deal. It's a complex disease. Many things can cause it. Food, surroundings, and genes all play a role. They can lead to long-term inflammation. This inflammation can start with bowel disease. It can end with cancer. But how do these factors work together? And what's next in res

reading time less than a minute
Jul 23 2025HEALTH

Small Choices, Big Impact: How Daily Habits Shape Colorectal Cancer Risks

Colorectal cancer is a major health issue, and it's not just bad luck. What we do every day, like eating, exercising, and other habits, can make a big difference. The big question is: how much of a difference can these changes really make? Experts are still working to figure out exactly how much of

reading time less than a minute
Jul 10 2025HEALTH

Unraveling the Secrets of Aging and Colorectal Cancer

Colorectal cancer (CRC) is a disease that often strikes older adults. Scientists have been studying how our bodies age at a cellular level, using something called DNA methylation (DNAm) to measure this. This process can show how old our cells really are, not just how old we are in years. Interestin

reading time less than a minute
Jul 06 2025HEALTH

Is Capecitabine Worth the Cost for Treating Colorectal Cancer?

Colorectal cancer is a serious health issue. Many people ask if capecitabine is a good choice for treatment. A recent study looked at the cost and benefits of this drug compared to active monitoring. The study focused on patients with stable or responding metastatic colorectal cancer after 16 weeks

reading time less than a minute
Jul 04 2025HEALTH

What You Eat After a Colorectal Cancer Diagnosis Matters

Colorectal cancer is a serious diagnosis. But did you know that what you eat and how you live your life after getting this diagnosis can make a big difference? A recent study looked at lots of other studies to see how diet and lifestyle affect survival rates for people with colorectal cancer. The f

reading time less than a minute
Jun 15 2025HEALTH

Early Screening: The Key to Beating Colorectal Cancer

Colorectal cancer is a serious and widespread health issue. It is expected to cause nearly 53, 000 deaths in the US this year. This type of cancer is becoming more common among younger adults, which is a worrying trend that scientists are trying to understand. Early detection and prevention are cruc

reading time less than a minute
Jun 09 2025HEALTH

UAE's Fight Against Colon Cancer: Awareness and Lifestyle Gaps

Colon cancer is a big deal worldwide, and it's becoming more common in the Middle East. In the UAE, more young people are getting diagnosed, which is worrying. This is likely due to bad lifestyle choices. A recent study looked into how much people in the UAE know about colon cancer and how they try

reading time less than a minute
Jun 02 2025HEALTH

Pfizer's CEO Speaks Out on Vaccine Controversy

The US Department of Health and Human Services recently made a bold move. They ended a contract with Moderna. The contract was for developing an mRNA vaccine for bird flu. The reason given was that mRNA technology is not well-tested. This decision sparked a response from Pfizer's CEO, Dr. Albert Bou

reading time less than a minute